News
Events
Research
Ways to help
About us
Contact Us
DONATE NOW
EVENTS
ANNUAL BALL
CONTACT US
SIGN UP TO NEWSLETTER
Jun 2011
Prevention Study
Aug 2011
Breakthrough research holds clues about MS cause
Jan 2012
2012 Funding
Sep 2009
Professor Prineas' findings revolutionize world-wide understanding
Nov 2009
Trish Foundation's funds multiplied
Aug 2010
More than 20 genes now identified
Oct 2010
Trish funding goes a long way
Feb 2011
2011 Funding

 

Second Round of Funding

In 2004 the Trish Foundation’s second round of funding for research grants, committed a further $250,000 for research into the pursuit of a cure or preventive strategy for multiple sclerosis.

The Trish Foundation and Multiple Sclerosis Australia called for applications for research which were jointly branded and were overwhelmed by the number of worthy applications for research, all of which could not be funded.

Applications were assessed internationally and were ranked by the Medical and Research Advisory Board of MS Australia, following which the Trish Foundation’s honorary Scientific Research Committee recommended the following projects which met the firm funding guidelines of the Trish Foundation to the Foundation’s Board for approval:

Dr Judith Greer and Professor Michael Pender – Royal Brisbane Hospital, Queensland
Dr Heinrich Korner – James Cook University, Queensland
Dr P Cabot, Dr S Roberts-Thomson, Dr G Monteith and Ms M Peitis – University of Queensland
Mr Attila Szvetko – Griffith University, Queensland

The four projects which the Foundation funded were all Queensland-based and addressed fundamental aspects of causation or prevention.

Foundation Scientific Research Committee member Professor Peter Russell said, “Momentum is gathering in the quest to eradicate this disease. The part our Foundation plays should not be underestimated, as it underpins the fragile research funding in Australia into multiple sclerosis and its causes.”

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.